Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Surrozen, Inc. (SRZN)
Company Research
Source: Yahoo! Finance
the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration, with a focus on severe eye diseases, today announced financial results for the third quarter ended September 30, 2025, and provided a business update. Business Highlights Surrozen remains focused on its ophthalmology pipeline, leveraging its Wnt biology expertise and antibody technologies to develop novel treatments for severe eye diseases. Key Third Quarter Events and Planned Fourth Quarter Scientific Meetings in 2025 Ophthalmology Pipeline: The Company continues to progress its lead candidates, SZN-8141 and SZN-8143 in retinal diseases and remains on track to submit an Investigational New Drug (IND) application for SZN-8141 in 2026 Scientific Presentations Highlighting Next Generation Surrozen Wnt Therapeutics for Retinal Diseases The Company's Vice President of Clinical Development, Daniel Chao, M.D., Ph.D.
Show less
Read more
Impact Snapshot
Event Time:
SRZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRZN alerts
High impacting Surrozen, Inc. news events
Weekly update
A roundup of the hottest topics
SRZN
News
- Surrozen (NASDAQ:SRZN) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=SRZN&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> tMarketBeat
- Surrozen to Present at Upcoming Healthcare Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Surrozen to Present at Upcoming Healthcare Investor ConferencesGlobeNewswire
- Surrozen (NASDAQ:SRZN) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.MarketBeat
- Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
SRZN
Sec Filings
- 12/2/25 - Form 4
- 11/20/25 - Form SCHEDULE
- 11/17/25 - Form 4
- SRZN's page on the SEC website